1. Petroni NC, Cardoni AA. Alcohol content of liquid medicinals. Clin Toxicol 1979; 14:407-432.
2. Vogel C, Caraccio T, Mofenson H, Hart S. Alcohol intoxication in young children. Clin Toxicol 1995; 33:25-33.
3. Charness ME, Simon RP, Greenberg DA. Ethanol and the nervous system. N Engl J Med 1989; 321:442-454.
4. Diamond I, Messing RO. Neurologic effects of alcoholism. West J Med 1994; 161:279-287.
5. Adler RA. Clinically important effects of alcohol on endocrine function. J Clin Endocrinol Metab 1992; 74:957–960.
6. Lieber CS. Hepatic and metabolic effects of ethanol: pathogenesis and prevention. Ann Med 1994; 26:325–330.
7. Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995; 333:1058–1065.
8. Yang HY, Lin HS, Chao JC, Chien YW, Peng HC, Chen JR. Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdrawal. J Nut Biochem 2012; 23:679-684.
9. Darwish HA, Abd Raboh NR, Mahdy A. Camel’s milk alleviates alcohol-induced liver injury in rats. Food Chem Toxicol 2012; 50 1377-1383.
10. Hossein Hosseinzadeh SP. Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus. Phytomedicine 2007; 14:621–627.
11. Jansen PM. Spices, Condiments and Medicinal Plants in Ethiopia, their Taxonomy and Agricultural Significance. Wageningen, The Netherlands: Centre for Agricultural Publishing and Documentation. 1981:194-205.
12. Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann Allergy 1993; 70:237-242.
13. el-Dakhakhny M. Studies on the Egyptian Nigella sativa L. IV. Some pharmacological properties of the seeds' active principle in comparison to its dihydro compound and its polymer. Arzneimittelforschung 1965; 15:1227-1229.
14. Mahfouz M, Abdel-Maguid R, El-Dakhakhny M. The effect of ‘‘nigellone therapy’’ on the histaminopexic power of the blood sera in asthmatic patients. Arzneimittelforschung 1965; 15:1230–1234.
15. El Tahir KE, Ashour M, Al-Harbi MM. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen Pharmacol 1993; 24: 1123-1131.
16. Al-Ghamdi M. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol 2001; 76:45-48.
17. Houghton PJ, Zarka R, de las Heras B, Hoult J. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995; 61: 33-36.
18. Abdel-Fattah A-FM, Matsumoto K, Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol 2000; 400: 89-97.
19. Al-Hader A, Aqel M, Hasan Z. Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Pharmaceut Biol 1993; 31:96-100.
20. Topozada HH, Mazolum HA, El-Dakhakhny M. The antibacterial properties of Nigella sativa seeds, active principle with some clinical applications. J Egypt Med Assoc 1965; 48:187–202.
21. Hanafy MS
, Hatem ME
. Studies on the antimicrobial activity of Nigella sativa
seed black cumin. J Ethnopharmacol 1991; 34:275–278.
22. Salomi N, Nair S, Jayawardhanan K, Varghese C, Panikkar L. Anti-tumor principles from Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer 1992; 16:67-72.
23. Hosseinzadeh H, Parvardeh S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine 2004; 11:56-64.
24. Hosseinzadeh H, Parvardeh S, Nassiri-Asl M, Mansouri MT. Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med Sci Monit 2005; 11:BR106-BR110.
25. Hosseinzadeh H, Jaafari MR, Khoei AR, Rahmani M. Anti-ischemic effect of Nigella sativa L. seed in male rats. Iran J Pharm Res 2006; 5:53-58.
26. Worthen DR, Ghosheh OA, Crooks PA. The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res 1998; 18:1527-1532.
27. Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000; 14:323-328.
28. Riaz M, Syed M, Chaudhary FM. Chemistry of the medicinal plants of the genus Nigella. Hamdard Medicus 1996; 39:40–45.
29. Ali BH, Blunden G. Pharmacological and Toxicological Properties of Nigella sativa. Phytother Res 2003; 17:299–305.
30. Mahfouz M, Abdel-Meguid R, El-Dakhakimy M. Effectiveness of ‘Nigella’ in asthma. Alexandria Med J 1960; 6: 543–547.
31. D’Antuono LF, Moretti A, Lovato A. Seed yield, yield components, oil content and essential oil content and composition of Nigella sativa L. and Nigella damascene L. Indust Crops Prod 2002; 15:59–69.
32. Niehaus WG Jr, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968; 6:126–130.
33. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S transferase activities in rat lung and liver. Biochim Biophys Acta 1979; 582:67–78.
35. Scott RB, Reddy KS, Husain K, Schlorff EC, Rybak LP, Somani SM. Dose response of ethanol on antioxidant defense system of liver, lung, and kidney in rat. Pathophysiology 2000; 7:25-32.
36. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002; 27:63-68.
37. Yoon SJ, Koh EJ, Kim CS, Jee OP, Kwak JH, Jeong WJ, et al. Agrimonia eupatoria protects against chronic ethanol-induced liver injury in rats. Food Chem Toxicol 2012; 50:2335-2341.
38. Arslan SO, Ethem Gelir TE, Armutcu F, Coskun O, Gurel A, Hale Sayan, et al. The protective effect of thymoquinone on ethanol-induced acute gastric damage in the rat. Nutr Res 2005; 25:673–680.
39. El-Dakhakhny M, Barakat M, Abd El-Halim M, Aly SM. Effects of Nigella sativa oil on gastric secretion and ethanol induced ulcer in rats. J Ethnopharmacol 2000; 72:299-304.
40. Lu ZM
, Tao WY
, Zou XL
, Fu HZ
, Ao ZH
. Protective effects of mycelia of Antrodia camphorata and Armillariella tabescens in submerged culture against ethanol-induced hepatic toxicity in rats. J Ethnopharmacol 2007; 110:160-164.
41. Esposito E, Cuzzocrea S. TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem 2009; 16:3152–3167.
42. Shirpoor A, Minassian S, Salami S, Khadem-Ansari MH, Ghaderi-Pakdel F, Yeghiazaryan M. Vitamin E protects developing rat hippocampus and cerebellum against ethanol-induced oxidative stress and apoptosis. Food Chem 2009; 113:115-120.
43. El Daly E. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Belg 1998; 53:87-93.
44. El-Dakhakhny M, Mady NI, Halim MA. Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneimittelforschung 2000; 50:832-836.
45. Mansour MA. Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice. Life Sci 2000; 66:2583-2591.
46. Helal GK. Thymoquinone supplementation ameliorates acute endotoxemia-induced liver dysfunction in rats. Pak J Pharm Sci 2010; 23:131-137.
47. Fadeel B, Orrenius S, Zhivotovsky B. Apoptosis in human disease: a new skin for the old ceremony? Biochem Biophys Res Commun 1999; 266:699-717.
48. Kumar S, Sitasawad SL. N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells. Life Sci 2009; 84:328-336.
49. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35:495-516.
50. Frenzel A, Grespi F, Chmelewskij W, Villunger A. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis 2009; 14:584–596.
51. Scorrano L, Korsmeyer S. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 2003; 304:437–444.
52. Abd El-Ghany RM, Sharaf NM, Kassem LA, Mahran LG, Heikal OA. Thymoquinone triggers anti-apoptotic signaling targeting death ligand and apoptotic regulators in a model of hepatic ischemia reperfusion injury. Drug Discov Ther 2009; 3:296-306.